Janux Therapeutics, Inc. (JANX)

SEC filing

Janux Therapeutics, Inc.

JANX · CIK 1817713

4 · Jan 2, 2026 · DiRaimondo Thomas sold 2,505 shares at $13.73/share ($34,394); was granted 31.40K shares

DiRaimondo Thomas sold 2,505 shares at $13.73/share ($34,394); was granted 31.40K shares

xslF345X05/form4-01022026_090110.xml

xslF345X05/form4-01022026_090110.xmlSEC.gov

Graphics and non-inline formats (not embedded below).